ATP (Apple Tree Partners)

Apple Tree Partners (ATP) is a leading life sciences venture capital firm with a 25-year track record of successfully translating scientific advancements into novel, innovative treatments. With over $2.9 billion in committed capital, ATP operates from offices in New York, South San Francisco, and Cambridge, MA. ATP's core strategy is to provide flexible capital and access to a world-class team, enabling the development of sustainable, research-driven enterprises that deliver life-changing therapeutics.

ATP actively creates and invests in companies at all stages of development, from early-stage pre-IP ideas to asset spinouts. Their portfolio spans various therapeutic areas, including oncology, neurology, immunology, and infectious diseases. ATP's commitment to supporting their portfolio companies extends beyond seed stage, as they actively participate in their growth, from seed stage through IPO and beyond. This holistic approach and focus on building sustainable enterprises has resulted in numerous successful exits and significant contributions to the advancement of human health.

Apple Tree Partners (ATP) is a leading life sciences venture capital firm dedicated to creating and investing in companies that translate scientific advances into innovative treatments improving human lives. Their mission is to provide flexible capital, strategic insight, and operational resources to build sustainable, research-driven enterprises that deliver therapeutics across a range of diseases. They invest in companies at various stages of development, from pre-IP ideas to asset spinouts, supporting them from seed stage through IPO and beyond.

Apple Tree Partners fosters a culture of innovation and collaboration, prioritizing scientific excellence and a commitment to building sustainable, research-driven enterprises that improve human lives. The company's team comprises experienced venture capitalists, scientists, and business professionals who work together to identify and support promising life sciences companies at various stages of development.